Baseline Characteristics
| Characteristic | Data |
| Total patients (n) | 22 (100%) |
| Sex (n) | |
| Male | 11 (50%) |
| Female | 11 (50%) |
| Mean age (y) | |
| All patients | 59 (range, 30–82) |
| Female | 58 (range, 39–73) |
| Male | 61 (range, 30–82) |
| ECOG status (n) | |
| 0 | 16 (73%) |
| 1 | 6 (27%) |
| Time from diagnosis of uveal melanoma to liver metastases (mo) | |
| Mean | 34.9 (95%CI, 19.7–50.1) |
| Median | 19 (range, 0–144) |
| Time from diagnosis of liver metastases to first SIRT (mo) | |
| Mean | 2.7 (95%CI, 2.3–3.1) |
| Median | 3 (range, 1–5) |
| No. of patients with extrahepatic metastases before SIRT (n) | 4 (18%) |
| Liver tumor distribution (n) | |
| Whole liver | 20 (91%) |
| Unilobar | 2 (9%) |
| Liver tumor volume (cm3) | |
| Mean | 318.1 (95%CI, 82.6–553.6) |
| Median | 130 (range, 10–2,750) |
| Largest liver tumor (cm) | |
| Mean | 4.1 (95%CI, 2.4–5.8) |
| Median | 2.6 (range, 1.4–18.6) |
| Number of liver metastases (n) | |
| 0–10 | 13 (59%) |
| >11 | 9 (41%) |
| Tumor-to-liver uptake ratio* | |
| Mean | 4.0 (95%CI, 3.1–4.9) |
| Median | 3.5 (range, 1–10) |
| SUVmax | |
| Mean | 7.5 (95%CI, 5.6–9.4) |
| Median | 7.4 (range, 3.3–22.1) |
↵* 99mTc-macroaggregated albumin SPECT/CT.